JCROA Member Sales Increased 2.9% In 2013
This article was originally published in PharmAsia News
Total sales of the 28 member companies in the Japan CRO Association grew 2.9% in 2013 to ¥136.8 billion ($1.33 billion), according to an announcement by the association.
You may also be interested in...
Two leading, independent bodies of French scientists, doctors and pharmacists are calling for OTC drugs containing pseudoephedrine to be reverse-switched to prescription-only status over safety fears.
COVID-19 has shifted consumer health behaviour towards prevention and general wellbeing. However, finding out what consumers actually want and need is still the essence of good OTC innovation, according to Stada Arzneimittel's new vice president of consumer healthcare product development Steve Makin.
Swiss biotech Molecular Partners will receive upfront payment of CHF 60m, including equity.